Cargando…
Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease
Genetic mutations that severely diminish the activity of aspartoacylase (ASPA) result in the fatal brain dysmyelinating disorder, Canavan disease. There is no effective treatment. ASPA produces free acetate from the concentrated brain metabolite, N-acetylaspartate (NAA). Because acetyl coenzyme A is...
Autores principales: | Arun, Peethambaran, Madhavarao, Chikkathur N., Moffett, John R., Hamilton, Kristen, Grunberg, Neil E., Ariyannur, Prasanth S., Gahl, William A., Anikster, Yair, Mog, Steven, Hallows, William C., Denu, John M., Namboodiri, Aryan M. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877317/ https://www.ncbi.nlm.nih.gov/pubmed/20464498 http://dx.doi.org/10.1007/s10545-010-9100-z |
Ejemplares similares
-
N-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation
por: Moffett, John R., et al.
Publicado: (2013) -
Increasing N-acetylaspartate in the Brain during Postnatal Myelination Does Not Cause the CNS Pathologies of Canavan Disease
por: Appu, Abhilash P., et al.
Publicado: (2017) -
Acetate Revisited: A Key Biomolecule at the Nexus of Metabolism, Epigenetics, and Oncogenesis – Part 2: Acetate and ACSS2 in Health and Disease
por: Moffett, John R., et al.
Publicado: (2020) -
Clinically Distinct Phenotypes of Canavan Disease Correlate with Residual Aspartoacylase Enzyme Activity
por: Mendes, Marisa I, et al.
Publicado: (2017) -
Acss2 Deletion Reveals Functional Versatility via Tissue-Specific Roles in Transcriptional Regulation
por: Vasudevan, Narayanan Puthillathu, et al.
Publicado: (2023)